Add to notifications

genetic engineering

Processes involving genetic manipulation

Corporate and venture capital activity

Historical investment trends and number of deals for genetic engineering

Top 10 Recent Deals - last 24 months

Company Country Status Amount 
Company: Crispr Therapeutics Country: United States Status: Public Amount: $140,000,000
Company: Ginkgo Bioworks Country: United States Status: Private Amount: $100,000,000
Company: Novogene Country: China Status: Private Amount: $75,000,000
Company: Ginkgo Bioworks Country: United States Status: Private Amount: $45,000,000
Company: Synthego Country: United States Status: Private Amount: $41,000,000
Company: Agrivida Country: United States Status: Private Amount: $20,400,000
Company: Agrisoma Country: Canada Status: Private Amount: $15,400,000
Company: M2i Life Sciences Country: France Status: Private Amount: $13,511,806
Company: Roslin Technologies Country: United Kingdom Status: Private Amount: $12,400,000
Company: Chempolis Country: Finland Status: Private Amount: $11,306,152

Top 10 Investors - in last 24 months

Want to access this data?

Top 5 Acquirers - in last 24 months

Want to access this data?

Preload svg text font